Surveys

NASCSA periodically conducts surveys of its members and other interested parties on a variety of topics, including important questions related to controlled substances, registration, and Prescription Monitoring Programs (PMPs).

Click on the survey below to access the results in PDF format. 

    • Member Survey Summary – June, 2023 -NASCSA conducted a survey of its members in 2023 to measure their satisfaction with their membership, programs, policies, and the future direction of the organization. The goal was to allow the organization to more effectively evaluate its current offerings and identify areas for improvement. The results of our findings can be found here. 
    • NASCSA Gabapentin Survey – March, 2022 – In March of 2022, NASCSA conducted a survey of its state members requesting their input on a recent petition submitted Public Citizen to the FDA and DEA to place gabapentin and gabapentin enacarbil on schedule V of the Controlled Substances Act. Attached please find the results of the survey that showed overwhelming support for rescheduling the drug to Schedule V and a letter to FDA sharing the survey results.
    • NASCSA PMP Survey – January, 2019 – In 2019, NASCSA conducted a survey of state Prescription Monitoring Programs (PMPs) specifically related to data collected on veterinarian prescriptions. The results of the survey can be found here.